SCALE Performance

Cagrilintide Pen certificate of analysis, lot PL-2610-032

Certificate PL-26-00154 reports the release tests for Cagrilintide Pen lot PL-2610-032: 99.38% purity by reverse-phase HPLC and identity confirmed by LC-MS, tested October 2, 2026. The lot number printed on each unit matches this certificate.

Certificate numberPL-26-00154
Lot numberPL-2610-032
CompoundCagrilintide Pen 20 mg
Sequence(C20 diacid-γGlu)-KCNTATCATQRLAEFLRHSSNNFGPILPPTNVGSNTP-NH₂ (37 residues; Cys2–Cys7 disulfide; Lys1 acylated with eicosanedioic acid via γ-Glu; C-terminal amide)
Molecular formulaC194H312N54O59S2
CAS number1415456-99-3
Purity (RP-HPLC)99.38%
Identity (LC-MS)Conforms (4,409.13 Da) · expected 4409 Da, found 4409.13 Da
MethodRP-HPLC (UV 214 nm) + LC-MS
TestedOctober 2, 2026
Retest byOctober 1, 2028
Tested byManufacturer’s in-house laboratory (not an independent third-party test)
ConclusionConforms

Tests run on this lot

TestMethodSpecificationResult
Identity (mass)LC-MS, ESI positiveTheoretical ± 1.0 Da4,409.13 Da (PASS)
PurityRP-HPLC, UV 214 nm, area%≥ 99.0%99.38% (PASS)
Largest impurityRP-HPLC, area%≤ 1.0%0.24% (RT 10.50) (PASS)
Assay (label claim)Assay vs label claim19–21 mg/mL20.35 mg/mL (PASS)
Bacterial endotoxinLAL, kinetic≤ 5.0 EU/mg0.276 EU/mg (PASS)
SterilityUSP <71>, 14-dayNo growthNo growth (PASS)

What these results mean

HPLC purity is the share of UV-detectable material that elutes as the target compound; it is not the same as net peptide content, which also accounts for water and counter-ions. Identity means the measured mass matched the mass calculated for the compound. A certificate reports only the tests run on this lot; endotoxin, sterility and contaminant panels are not part of standard lot release. How to read a certificate of analysis.

Cagrilintide Pen · Verify this certificate · All certificates

All Cagrilintide Pen certificates

All products currently listed on this site are for research purposes only. Peptides are strictly for laboratory, academic, or institutional research and not for human or animal consumption. Products have not been evaluated by the U.S. Food and Drug Administration and are not intended to diagnose, treat, cure or prevent any disease.